期刊文献+

感染病原体新型分子检测技术 GeneXpert 被引量:14

A novel molecular point-of-care testing detection technology for infectious pathogens:GeneXpert
原文传递
导出
摘要 近年来开展应用的GeneXpert分子生物学检测系统,整合了定量PCR分子检测过程中的样品制备、核酸纯化、基因扩增、结果报告等步骤并将其自动化,具有准确、快速、安全性高等特点,已成为新型分子POCT检测技术平台,为感染性病原体的检测提供了新的手段,尤其是在结核病的诊断方面具有重要意义。在此,介绍GeneXpert的检测原理、在感染病原体诊断方面的临床应用以及存在问题与发展趋势。 GeneXpert is an advanced molecular biological detection system developed in recent years, it integrates and automates the sample preparation , nucleic acid purification, gene amplification, results report of the fluorescent quantitative PCR process.As, an accurate, rapid, biosafe technology , GeneXpert has become one of the novel molecular POCT detection technology platforms for diagnosis of infectious pathogens and especially declared it a major milestone for global TB diagnosis .This paper introduces the detection principle , clinical application in the detection of infectious pathogens , limitation and prospect of GeneXpert.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第11期820-823,共4页 Chinese Journal of Laboratory Medicine
基金 第四军医大学西京医院学科助推计划重大临床技术项目(XJZTl0203)
关键词 床旁诊断化验信息系统 细菌学技术 分子诊断技术 分枝杆菌 结核 结核 试剂盒 诊断 Point-of-care systems Bacteriological techniques Molecular diagnostictechniques Mycobacterimn tuberculosis Tuberculosis Reagent kits, diagnostic
  • 相关文献

参考文献17

  • 1Sturenburg E, Junker R. Point-of-care testing in microbiology:the advantages and disadvantages of immunochromatographic test strips[J]. Dtsch Arztebl Int, 2009, 106:48-54.
  • 2Moore C. Point-of-care tests for infection control:should rapid testing be in the laboratory or at the front line[J]? J Hosp Infect, 2013,85:1-7.
  • 3Endimiani A, Hujer KM, Hujer AM, et al. Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia [J] ? Clin Infect Dis, 2011,52 : S373-S383.
  • 4Fournier PE, Drancourt M, Colson P, et al. Modem clinical microbiology:new challenges and solutions[ J]. Nat Rev Microbiol, 2013, 11:574- 585.
  • 5Raja S, Ching J, Xi L, et al. Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing[J]. Clin Chem, 2005, 51:882-890.
  • 6刘家云,徐修礼,孙惠平,龙铟,钱妙玲,张鹏亮,樊新,程晓东,马越云,苏明权,陈超扬,郝晓柯.耐药结核分枝杆菌基因突变分析[J].中华检验医学杂志,2010,33(7):594-598. 被引量:9
  • 7Lin SY, Desmond EP. Molecular diagnosis of tuberculosis and drug resistance[J]. Clin Lab Med, 2014, 34:297-314.
  • 8Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance[J]. N Engl J Med, 2010, 363: 1005-1015.
  • 9刘家云,郝晓柯.结核病实验室诊断方法新进展[J].临床检验杂志,2013,31(2):115-117. 被引量:32
  • 10Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa:a muhicentre, randomised, controlled trial[ J]. Lancet, 2014, 383:424-435.

二级参考文献25

  • 1Baneijee R,Schecter CF,Flood J,et al.Extensively drug-resistant tuberculosis:new strains,new challenges.Expert Rev Anti Infect Ther,2008,6:713-724.
  • 2Gandhi NR,Moll A,Sturm AW,et al.Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.Lancet,2006,368:1554-1556.
  • 3Sandgren A,Strong M,Muthukrishnan P,et al.Tuberculosis drug resistance mutation database.PLoS Med,2009,6:e2.
  • 4Rüsch-Gerdes S,Pfyffer GE,Casal M,et al.Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical secondline drugs and newer antimicrobials.J Clin Microbiol,2006,44:688-692.
  • 5Chan RC,Hui M,Chan EW,et al.Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong.J Antimicrob Chemother,2007,59:866-873.
  • 6Migliori GB,D'Arcy Richardson M,Sotgiu G,et al.Multidrugresistant and extensively drug-resistant tuberculosis in the West.Europe and United States;epidemiology,surveillance,and control.Clin Chest Med,2009,30:637-665.
  • 7Hillemann D,Weizenegger M,Kubica T,et al.Use of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.J Clin Microbiol,2005,43:3699-3703.
  • 8Luo T,Zhao M,Li X,et al.Selection of mutations to detect MDR TB in Shanghai,China.Antimicrob Agents Chemother,2010,54:1075-1081.
  • 9Miotto P,Saleri N,Dembelé M,et al.Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso.BMC Infect Dis,2009,28(9):142.
  • 10Starks AM,Gumusboga A,Plikaytis BB,et al.Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.Antimicrob Agents Chemother,2009,53:1061-1066.

共引文献39

同被引文献133

引证文献14

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部